Cadmium induced p53-dependent activation of stress signaling, accumulation of ubiquitinated proteins, and apoptosis in mouse embryonic fibroblast cells.
The tumor suppressor oncoprotein, p53, is a critical regulator of stress-induced growth arrest and apoptosis. p53 activity is regulated through the ubiquitin proteasome system (UPS) with stress-induced disruption leading to increased accumulation of p53, resulting in growth arrest. In the present study, we investigate the role of p53 to determine sensitivity to cadmium (Cd) and whether induction of stress signaling responses and perturbation of the UPS are involved in Cd-induced cytotoxicity and apoptosis. We treated synchronously cultured p53 transgenic mouse embryonic fibroblasts, both wild-type p53+/+ and knockout p53-/- cells, with cadmium chloride (Cd, 0.5-20μM) for 24 h. Cd-induced cytotoxicity was assessed by cellular morphology disruption and neutral red dye uptake assay. Proteins in the stress signaling pathway, including p38 mitogen-activated protein kinase (MAPK) and stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK); ubiquitination, such as high-molecular weight of polyubiquitinated proteins (HMW-polyUb); and apoptotic pathways, were all measured. We found that Cd induced p53-dependent cytotoxicity in the p53+/+ cells, which exhibited a twofold greater sensitivity. We observed a dose-dependent stimulation of p38 MAPK and SAPK/JNK phosphorylation that corresponded to accumulation of HMW-polyUb conjugates and lead to the induction of apoptosis, as evidenced by the elevation of cleaved caspase-3. Our study suggests that Cd-mediated cytotoxicity and induction of stress signaling responses, elevated accumulation of HMW-polyUb conjugates, and resulting apoptosis are all dependent on p53 status.
Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington 98105, USA .
Xiaozhong
X
Yu
Jaspreet S
JS
Sidhu
Sungwoo
S
Hong
Joshua F
JF
Robinson
Rafael A
RA
Ponce
Elaine M
EM
Faustman
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D015153:Blotting, Western; D019256:Cadmium Chloride / Q000633:toxicity*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004622:Embryo, Mammalian / Q000166:cytology; D004785:Environmental Pollutants / Q000633:toxicity*; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D047468:Immunoprecipitation; D051379:Mice; D018345:Mice, Knockout; D010766:Phosphorylation; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D013312:Stress, Physiological / Q000187:drug effects*; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000502:physiology*; D057149:Ubiquitinated Proteins / Q000378:metabolism*
D004785:Environmental Pollutants; D016159:Tumor Suppressor Protein p53; D057149:Ubiquitinated Proteins; D046988:Proteasome Endopeptidase Complex; D019256:Cadmium Chloride
Toxicol Appl Pharmacol. 2007 Jan 15;218(2):174-85
17174997
J Neurosci. 2003 Feb 15;23(4):1237-45
12598612
J Biol Chem. 2003 Jan 24;278(4):2396-402
12441344
J Cell Physiol. 2002 Jul;192(1):1-15
12115731
Environ Health Perspect. 2002 Oct;110 Suppl 5:865-7
12426148
Biochem Pharmacol. 2000 Dec 15;60(12):1875-82
11108803
Toxicol Sci. 2005 Apr;84(2):378-93
15659572
Int J Biochem Cell Biol. 2003 May;35(5):716-27
12672463
Exp Cell Res. 2010 May 1;316(8):1289-95
20149791
Cell Stress Chaperones. 2010 May;15(3):323-34
19838833
Oncogene. 2001 Apr 5;20(15):1803-15
11313928
Toxicol Sci. 2008 Aug;104(2):385-96
18463101
Nat Methods. 2010 Jun;7(6):473-8
20453865
FEBS Lett. 2002 Mar 27;515(1-3):8-12
11943185
J Biol Chem. 2001 Dec 7;276(49):46073-8
11598140
Toxicol Appl Pharmacol. 2009 Sep 15;239(3):325-36
19560483
Curr Opin Clin Nutr Metab Care. 2007 Jan;10(1):24-31
17143051
Toxicol Appl Pharmacol. 2008 Dec 15;233(3):389-403
18929588
Toxicol Lett. 1985 Feb-Mar;24(2-3):119-24
3983963
Nature. 1993 Jan 28;361(6410):369-71
8381213
Toxicol Sci. 2009 Jan;107(1):206-19
18974090
Toxicol Appl Pharmacol. 2000 May 1;164(3):291-300
10799339
J Biol Chem. 2002 Jul 12;277(28):25283-9
11997384
Toxicol Appl Pharmacol. 2009 Aug 1;238(3):209-14
19236887
Toxicol Sci. 2010 Apr;114(2):356-77
20061341
Mol Cell Biochem. 2009 Oct;330(1-2):83-95
19363675
Lab Invest. 2002 Aug;82(8):965-80
12177235
Cell Physiol Biochem. 1999;9(3):117-25
10494025
Toxicol Appl Pharmacol. 2003 Jul 1;190(1):17-24
12831779
Cancer Res. 2009 Feb 1;69(3):976-83
19176375
Exp Eye Res. 2009 Oct;89(4):494-502
19524565
Nat Cell Biol. 2008 Jun;10(6):676-87
18454141
Neurochem Res. 2003 Jan;28(1):15-27
12587660
Mol Biol Rep. 1997 Mar;24(1-2):35-8
9228278
J Chem Biol. 2009 Aug;2(3):113-29
19568783
World J Gastroenterol. 2009 Apr 14;15(14):1702-7
19360913
Toxicol Appl Pharmacol. 2009 Nov 15;241(1):81-9
19682480
Cell Growth Differ. 2000 May;11(5):239-46
10845424
J Biol Chem. 2002 Apr 19;277(16):13761-70
11827966
Blood. 2009 Mar 26;113(13):3040-9
19164601
Mutat Res. 2009 Apr 26;663(1-2):22-31
19475715
Oncogene. 1999 Nov 1;18(45):6145-57
10557106
J Biol Chem. 2002 Jun 21;277(25):22909-14
11948180
J Cell Physiol. 2002 Sep;192(3):327-38
12124778